LIZTOX Trademark

Trademark Overview


On Monday, December 23, 2019, a trademark application was filed for LIZTOX with the United States Patent and Trademark Office. The USPTO has given the LIZTOX trademark a serial number of 79277955. The federal status of this trademark filing is REGISTERED as of Tuesday, September 22, 2020. This trademark is owned by Huons Global Co., Ltd.. The LIZTOX trademark is filed in the Pharmaceutical Products category with the following description:

Food for babies; lactose for pharmaceutical purposes; nutritional supplements; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical products for the treatment of viral diseases; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals being medicines for alleviating constipation; pharmaceutical products for the treatment of bone diseases; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations, namely, ophthalmic preparations; pharmaceutical preparations for treating allergies; pharmaceutical products for the treatment of cancer; pharmaceutical agents for epidermis; pharmaceuticals being medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for t...
liztox

General Information


Serial Number79277955
Word MarkLIZTOX
Filing DateMonday, December 23, 2019
Status700 - REGISTERED
Status DateTuesday, September 22, 2020
Registration Number6155844
Registration DateTuesday, September 22, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 7, 2020

Trademark Statements


Goods and ServicesFood for babies; lactose for pharmaceutical purposes; nutritional supplements; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical products for the treatment of viral diseases; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals being medicines for alleviating constipation; pharmaceutical products for the treatment of bone diseases; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations, namely, ophthalmic preparations; pharmaceutical preparations for treating allergies; pharmaceutical products for the treatment of cancer; pharmaceutical agents for epidermis; pharmaceuticals being medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating asthma; pharmaceuticals being medicines for dental purposes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for respiratory organs; pharmaceuticals being antihistamines; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of diseases of the genitourinary system; pharmaceutical preparations for the prevention of diseases of the genitourinary system; pharmaceutical preparations for treating obesity; pharmaceuticals being cardiotonics; cardiovascular pharmaceuticals; pharmaceutical preparations, namely, antipyretic preparations; pharmaceutical preparations, namely, analgesic preparations; pharmaceutical preparations, namely, anti-inflammatory preparations; pharmaceuticals being anaesthetics; pharmaceutical products for the treatment of infectious diseases; pharmaceuticals being chemotherapeutics; pharmaceuticals being psychotropics; pharmaceutical products for skin care for animals; pharmaceutical preparations for the treatment of worms in pets; Veterinary preparations, namely, anti-infective products for veterinary use; Veterinary preparations, namely, veterinary vaccines; veterinary preparations for treatment of intestinal bacteria; food supplements; dietary supplements; nutraceuticals for use as dietary supplements; nutraceutical preparations for therapeutic or medical purposes for the treatment of obesity; nutraceutical preparations for therapeutic or medical purposes for the treatment of intestinal disorders; nutraceutical preparations for therapeutic or medical purposes for the treatment of allergies; nutraceutical preparations for therapeutic or medical purposes for the treatment of gastrointestinal diseases; medicated plasters; deodorants, other than for human beings or for animals, namely, air deodorants, deodorants for clothing, deodorants for textiles, household deodorants, and room deodorants; bacterial preparations for medical and veterinary use; medicine cases, portable, filled, with pharmaceutical preparations for the treatment of viral diseases; medicine cases, portable, filled, with pharmaceutical preparations for the treatment of intestinal disorders; medicine cases, portable, filled, with pharmaceutical preparations for the treatment of inflammatory diseases; sanitary pads; adhesives for dentures; diapers for incontinence; babies' diapers; diapers for pets; fly glue; mothproofing paper
Translation of Words in MarkThe wording "LIZTOX" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHuons Bio Pharma Co., Ltd.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressKR

Party NameHuons Global Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameHuons Global Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameHuons Global Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Saturday, August 28, 2021CHANGE OF OWNER RECEIVED FROM IB
Saturday, January 30, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 8, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 8, 2021FINAL DISPOSITION PROCESSED
Tuesday, December 22, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 22, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, July 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 17, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 1, 2020REFUSAL PROCESSED BY IB
Thursday, April 9, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, April 9, 2020REFUSAL PROCESSED BY MPU
Wednesday, March 25, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 24, 2020NON-FINAL ACTION WRITTEN
Thursday, March 19, 2020ASSIGNED TO EXAMINER
Saturday, February 15, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, February 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 10, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 6, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB